The efficacy and safety of sodium hyaluronate injection (Adant®) in treating degenerative osteoarthritis: a multi-center, randomized, double-blind, positive-drug parallel-controlled and non-inferiority clinical study
Objective To compare the efficacy and safety of two different sodium hyaluronate drugs in treating degenerative osteoarthritis (OA) of the knee. Method This randomized, multi‐center, double‐blind, positive‐drug, parallel‐controlled study included 229 patients aged ≥ 45 years who were clinically diag...
Gespeichert in:
Veröffentlicht in: | International journal of rheumatic diseases 2016-03, Vol.19 (3), p.271-278 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 278 |
---|---|
container_issue | 3 |
container_start_page | 271 |
container_title | International journal of rheumatic diseases |
container_volume | 19 |
creator | Xin, Yang Jianhao, Lin Tiansheng, Sun Yongqiang, Hao Weimin, Fan Ming, Chen Tiezheng, Sun Jianhua, Yao Liang, Xuan Xiaoyuan, Gu Yongping, Cao |
description | Objective
To compare the efficacy and safety of two different sodium hyaluronate drugs in treating degenerative osteoarthritis (OA) of the knee.
Method
This randomized, multi‐center, double‐blind, positive‐drug, parallel‐controlled study included 229 patients aged ≥ 45 years who were clinically diagnosed with degenerative OA of the knee. The patients were randomly assigned to receive for 5 consecutive weeks a once‐weekly intra‐articular injection of the investigational drug Adant®, which is manufactured by fermentation, or the control drug Artz®, which is manufactured by extraction of cockscomb. The follow‐up examinations were conducted 1, 2, 3, 4 and 6 weeks after the first injection. The primary efficacy parameter was the decrease in the visual analog scale (VAS) scores of pain on movement caused by load‐bearing, and the secondary efficacy parameter was the decrease in the Lequesne index.
Results
The intra‐articular injections of Adant® and Artz® produced a significant reduction in the VAS scores for pain on movement (50.4 and 50.3 mm, respectively) and in the Lequesne index. There were no significant differences in efficacy and safety between the two drugs and non‐inferiority in VAS score decreases was confirmed.
Conclusion
The results of this study show that both Adant® and Artz® are effective for the treatment of OA and that there were no statistical differences between them in the VAS scores of pain on movement, Lequesne index or safety during the observation period with short‐time follow up. |
doi_str_mv | 10.1111/1756-185X.12782 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1805512296</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1777076496</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5092-91da0f3e7cb08302a93c49e43f4825af28d0177678b5518db1493bb2c9922e843</originalsourceid><addsrcrecordid>eNqFksFu1DAURSMEoqWwZocssSlS08ZOHCfdjQoUpFEBqQjExnLslxkPjj3YDhA-io_gL_gbPDPtLNjUGz9b597nJ98se4qLU5zWGWa0znFDP59iwhpyLzvc39zf1xU-yB6FsCqKGpc1e5gdkJpS2tTkMPt7vQQEfa-lkBMSVqEgeogTcj0KTulxQMtJmNE7KyIgbVcgo3YWHc-UsPHP7xfpDkUPImq7QAoWYMGnw3dALkRwwsel11GHcyTQMJqocwk2gj9BPrVzg_4F6gQpN3YG8s5om05rF_TGIld-XKC18MIYMLl0NnqXSrV9qXU217YHr13qMCGZxGkOg0Ic1fQ4e9ALE-DJzX6UfXz96vriTT5_d_n2YjbPJS1akrdYiaIvgcmuaMqCiLaUVQtV2VcNoaInjSowYzVrOkpxozpctWXXEdm2hEBTlUfZ8c537d23EULkgw4SjBEW3Bg4bookJKSt70YZYwWrqy36_D905UZv0yAbqsa4IrRM1NmOkt6F4KHna68H4SeOC74JCN9EgG_iwLcBSYpnN75jN4Da87eJSADdAT-0gekuPz57P781znc6nX79514n_Fdes5JR_unqktPq5YerCn_hpPwHEvnZDw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1776114253</pqid></control><display><type>article</type><title>The efficacy and safety of sodium hyaluronate injection (Adant®) in treating degenerative osteoarthritis: a multi-center, randomized, double-blind, positive-drug parallel-controlled and non-inferiority clinical study</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Xin, Yang ; Jianhao, Lin ; Tiansheng, Sun ; Yongqiang, Hao ; Weimin, Fan ; Ming, Chen ; Tiezheng, Sun ; Jianhua, Yao ; Liang, Xuan ; Xiaoyuan, Gu ; Yongping, Cao</creator><creatorcontrib>Xin, Yang ; Jianhao, Lin ; Tiansheng, Sun ; Yongqiang, Hao ; Weimin, Fan ; Ming, Chen ; Tiezheng, Sun ; Jianhua, Yao ; Liang, Xuan ; Xiaoyuan, Gu ; Yongping, Cao</creatorcontrib><description>Objective
To compare the efficacy and safety of two different sodium hyaluronate drugs in treating degenerative osteoarthritis (OA) of the knee.
Method
This randomized, multi‐center, double‐blind, positive‐drug, parallel‐controlled study included 229 patients aged ≥ 45 years who were clinically diagnosed with degenerative OA of the knee. The patients were randomly assigned to receive for 5 consecutive weeks a once‐weekly intra‐articular injection of the investigational drug Adant®, which is manufactured by fermentation, or the control drug Artz®, which is manufactured by extraction of cockscomb. The follow‐up examinations were conducted 1, 2, 3, 4 and 6 weeks after the first injection. The primary efficacy parameter was the decrease in the visual analog scale (VAS) scores of pain on movement caused by load‐bearing, and the secondary efficacy parameter was the decrease in the Lequesne index.
Results
The intra‐articular injections of Adant® and Artz® produced a significant reduction in the VAS scores for pain on movement (50.4 and 50.3 mm, respectively) and in the Lequesne index. There were no significant differences in efficacy and safety between the two drugs and non‐inferiority in VAS score decreases was confirmed.
Conclusion
The results of this study show that both Adant® and Artz® are effective for the treatment of OA and that there were no statistical differences between them in the VAS scores of pain on movement, Lequesne index or safety during the observation period with short‐time follow up.</description><identifier>ISSN: 1756-1841</identifier><identifier>EISSN: 1756-185X</identifier><identifier>DOI: 10.1111/1756-185X.12782</identifier><identifier>PMID: 26555862</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Aged ; Disability Evaluation ; Double-Blind Method ; Drug Compounding ; Female ; Humans ; Hyaluronic Acid - administration & dosage ; Hyaluronic Acid - adverse effects ; Injections, Intra-Arterial ; Knee Joint - drug effects ; Knee Joint - physiopathology ; Male ; Middle Aged ; multi-center randomized controlled clinical study ; osteoarthritis ; Osteoarthritis, Knee - diagnosis ; Osteoarthritis, Knee - drug therapy ; Osteoarthritis, Knee - physiopathology ; Pain ; Pain Measurement ; Recovery of Function ; sodium hyaluronate ; Therapeutic Equivalency ; Time Factors ; Treatment Outcome ; Viscosupplements - administration & dosage ; Viscosupplements - adverse effects</subject><ispartof>International journal of rheumatic diseases, 2016-03, Vol.19 (3), p.271-278</ispartof><rights>2015 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd</rights><rights>2015 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.</rights><rights>International Journal of Rheumatic Diseases © 2016 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5092-91da0f3e7cb08302a93c49e43f4825af28d0177678b5518db1493bb2c9922e843</citedby><cites>FETCH-LOGICAL-c5092-91da0f3e7cb08302a93c49e43f4825af28d0177678b5518db1493bb2c9922e843</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1756-185X.12782$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1756-185X.12782$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26555862$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xin, Yang</creatorcontrib><creatorcontrib>Jianhao, Lin</creatorcontrib><creatorcontrib>Tiansheng, Sun</creatorcontrib><creatorcontrib>Yongqiang, Hao</creatorcontrib><creatorcontrib>Weimin, Fan</creatorcontrib><creatorcontrib>Ming, Chen</creatorcontrib><creatorcontrib>Tiezheng, Sun</creatorcontrib><creatorcontrib>Jianhua, Yao</creatorcontrib><creatorcontrib>Liang, Xuan</creatorcontrib><creatorcontrib>Xiaoyuan, Gu</creatorcontrib><creatorcontrib>Yongping, Cao</creatorcontrib><title>The efficacy and safety of sodium hyaluronate injection (Adant®) in treating degenerative osteoarthritis: a multi-center, randomized, double-blind, positive-drug parallel-controlled and non-inferiority clinical study</title><title>International journal of rheumatic diseases</title><addtitle>Int J Rheum Dis</addtitle><description>Objective
To compare the efficacy and safety of two different sodium hyaluronate drugs in treating degenerative osteoarthritis (OA) of the knee.
Method
This randomized, multi‐center, double‐blind, positive‐drug, parallel‐controlled study included 229 patients aged ≥ 45 years who were clinically diagnosed with degenerative OA of the knee. The patients were randomly assigned to receive for 5 consecutive weeks a once‐weekly intra‐articular injection of the investigational drug Adant®, which is manufactured by fermentation, or the control drug Artz®, which is manufactured by extraction of cockscomb. The follow‐up examinations were conducted 1, 2, 3, 4 and 6 weeks after the first injection. The primary efficacy parameter was the decrease in the visual analog scale (VAS) scores of pain on movement caused by load‐bearing, and the secondary efficacy parameter was the decrease in the Lequesne index.
Results
The intra‐articular injections of Adant® and Artz® produced a significant reduction in the VAS scores for pain on movement (50.4 and 50.3 mm, respectively) and in the Lequesne index. There were no significant differences in efficacy and safety between the two drugs and non‐inferiority in VAS score decreases was confirmed.
Conclusion
The results of this study show that both Adant® and Artz® are effective for the treatment of OA and that there were no statistical differences between them in the VAS scores of pain on movement, Lequesne index or safety during the observation period with short‐time follow up.</description><subject>Aged</subject><subject>Disability Evaluation</subject><subject>Double-Blind Method</subject><subject>Drug Compounding</subject><subject>Female</subject><subject>Humans</subject><subject>Hyaluronic Acid - administration & dosage</subject><subject>Hyaluronic Acid - adverse effects</subject><subject>Injections, Intra-Arterial</subject><subject>Knee Joint - drug effects</subject><subject>Knee Joint - physiopathology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>multi-center randomized controlled clinical study</subject><subject>osteoarthritis</subject><subject>Osteoarthritis, Knee - diagnosis</subject><subject>Osteoarthritis, Knee - drug therapy</subject><subject>Osteoarthritis, Knee - physiopathology</subject><subject>Pain</subject><subject>Pain Measurement</subject><subject>Recovery of Function</subject><subject>sodium hyaluronate</subject><subject>Therapeutic Equivalency</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><subject>Viscosupplements - administration & dosage</subject><subject>Viscosupplements - adverse effects</subject><issn>1756-1841</issn><issn>1756-185X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFksFu1DAURSMEoqWwZocssSlS08ZOHCfdjQoUpFEBqQjExnLslxkPjj3YDhA-io_gL_gbPDPtLNjUGz9b597nJ98se4qLU5zWGWa0znFDP59iwhpyLzvc39zf1xU-yB6FsCqKGpc1e5gdkJpS2tTkMPt7vQQEfa-lkBMSVqEgeogTcj0KTulxQMtJmNE7KyIgbVcgo3YWHc-UsPHP7xfpDkUPImq7QAoWYMGnw3dALkRwwsel11GHcyTQMJqocwk2gj9BPrVzg_4F6gQpN3YG8s5om05rF_TGIld-XKC18MIYMLl0NnqXSrV9qXU217YHr13qMCGZxGkOg0Ic1fQ4e9ALE-DJzX6UfXz96vriTT5_d_n2YjbPJS1akrdYiaIvgcmuaMqCiLaUVQtV2VcNoaInjSowYzVrOkpxozpctWXXEdm2hEBTlUfZ8c537d23EULkgw4SjBEW3Bg4bookJKSt70YZYwWrqy36_D905UZv0yAbqsa4IrRM1NmOkt6F4KHna68H4SeOC74JCN9EgG_iwLcBSYpnN75jN4Da87eJSADdAT-0gekuPz57P781znc6nX79514n_Fdes5JR_unqktPq5YerCn_hpPwHEvnZDw</recordid><startdate>201603</startdate><enddate>201603</enddate><creator>Xin, Yang</creator><creator>Jianhao, Lin</creator><creator>Tiansheng, Sun</creator><creator>Yongqiang, Hao</creator><creator>Weimin, Fan</creator><creator>Ming, Chen</creator><creator>Tiezheng, Sun</creator><creator>Jianhua, Yao</creator><creator>Liang, Xuan</creator><creator>Xiaoyuan, Gu</creator><creator>Yongping, Cao</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>201603</creationdate><title>The efficacy and safety of sodium hyaluronate injection (Adant®) in treating degenerative osteoarthritis: a multi-center, randomized, double-blind, positive-drug parallel-controlled and non-inferiority clinical study</title><author>Xin, Yang ; Jianhao, Lin ; Tiansheng, Sun ; Yongqiang, Hao ; Weimin, Fan ; Ming, Chen ; Tiezheng, Sun ; Jianhua, Yao ; Liang, Xuan ; Xiaoyuan, Gu ; Yongping, Cao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5092-91da0f3e7cb08302a93c49e43f4825af28d0177678b5518db1493bb2c9922e843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Aged</topic><topic>Disability Evaluation</topic><topic>Double-Blind Method</topic><topic>Drug Compounding</topic><topic>Female</topic><topic>Humans</topic><topic>Hyaluronic Acid - administration & dosage</topic><topic>Hyaluronic Acid - adverse effects</topic><topic>Injections, Intra-Arterial</topic><topic>Knee Joint - drug effects</topic><topic>Knee Joint - physiopathology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>multi-center randomized controlled clinical study</topic><topic>osteoarthritis</topic><topic>Osteoarthritis, Knee - diagnosis</topic><topic>Osteoarthritis, Knee - drug therapy</topic><topic>Osteoarthritis, Knee - physiopathology</topic><topic>Pain</topic><topic>Pain Measurement</topic><topic>Recovery of Function</topic><topic>sodium hyaluronate</topic><topic>Therapeutic Equivalency</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><topic>Viscosupplements - administration & dosage</topic><topic>Viscosupplements - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xin, Yang</creatorcontrib><creatorcontrib>Jianhao, Lin</creatorcontrib><creatorcontrib>Tiansheng, Sun</creatorcontrib><creatorcontrib>Yongqiang, Hao</creatorcontrib><creatorcontrib>Weimin, Fan</creatorcontrib><creatorcontrib>Ming, Chen</creatorcontrib><creatorcontrib>Tiezheng, Sun</creatorcontrib><creatorcontrib>Jianhua, Yao</creatorcontrib><creatorcontrib>Liang, Xuan</creatorcontrib><creatorcontrib>Xiaoyuan, Gu</creatorcontrib><creatorcontrib>Yongping, Cao</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xin, Yang</au><au>Jianhao, Lin</au><au>Tiansheng, Sun</au><au>Yongqiang, Hao</au><au>Weimin, Fan</au><au>Ming, Chen</au><au>Tiezheng, Sun</au><au>Jianhua, Yao</au><au>Liang, Xuan</au><au>Xiaoyuan, Gu</au><au>Yongping, Cao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The efficacy and safety of sodium hyaluronate injection (Adant®) in treating degenerative osteoarthritis: a multi-center, randomized, double-blind, positive-drug parallel-controlled and non-inferiority clinical study</atitle><jtitle>International journal of rheumatic diseases</jtitle><addtitle>Int J Rheum Dis</addtitle><date>2016-03</date><risdate>2016</risdate><volume>19</volume><issue>3</issue><spage>271</spage><epage>278</epage><pages>271-278</pages><issn>1756-1841</issn><eissn>1756-185X</eissn><abstract>Objective
To compare the efficacy and safety of two different sodium hyaluronate drugs in treating degenerative osteoarthritis (OA) of the knee.
Method
This randomized, multi‐center, double‐blind, positive‐drug, parallel‐controlled study included 229 patients aged ≥ 45 years who were clinically diagnosed with degenerative OA of the knee. The patients were randomly assigned to receive for 5 consecutive weeks a once‐weekly intra‐articular injection of the investigational drug Adant®, which is manufactured by fermentation, or the control drug Artz®, which is manufactured by extraction of cockscomb. The follow‐up examinations were conducted 1, 2, 3, 4 and 6 weeks after the first injection. The primary efficacy parameter was the decrease in the visual analog scale (VAS) scores of pain on movement caused by load‐bearing, and the secondary efficacy parameter was the decrease in the Lequesne index.
Results
The intra‐articular injections of Adant® and Artz® produced a significant reduction in the VAS scores for pain on movement (50.4 and 50.3 mm, respectively) and in the Lequesne index. There were no significant differences in efficacy and safety between the two drugs and non‐inferiority in VAS score decreases was confirmed.
Conclusion
The results of this study show that both Adant® and Artz® are effective for the treatment of OA and that there were no statistical differences between them in the VAS scores of pain on movement, Lequesne index or safety during the observation period with short‐time follow up.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>26555862</pmid><doi>10.1111/1756-185X.12782</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1756-1841 |
ispartof | International journal of rheumatic diseases, 2016-03, Vol.19 (3), p.271-278 |
issn | 1756-1841 1756-185X |
language | eng |
recordid | cdi_proquest_miscellaneous_1805512296 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Aged Disability Evaluation Double-Blind Method Drug Compounding Female Humans Hyaluronic Acid - administration & dosage Hyaluronic Acid - adverse effects Injections, Intra-Arterial Knee Joint - drug effects Knee Joint - physiopathology Male Middle Aged multi-center randomized controlled clinical study osteoarthritis Osteoarthritis, Knee - diagnosis Osteoarthritis, Knee - drug therapy Osteoarthritis, Knee - physiopathology Pain Pain Measurement Recovery of Function sodium hyaluronate Therapeutic Equivalency Time Factors Treatment Outcome Viscosupplements - administration & dosage Viscosupplements - adverse effects |
title | The efficacy and safety of sodium hyaluronate injection (Adant®) in treating degenerative osteoarthritis: a multi-center, randomized, double-blind, positive-drug parallel-controlled and non-inferiority clinical study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T11%3A56%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20efficacy%20and%20safety%20of%20sodium%20hyaluronate%20injection%20(Adant%C2%AE)%20in%20treating%20degenerative%20osteoarthritis:%20a%20multi-center,%20randomized,%20double-blind,%20positive-drug%20parallel-controlled%20and%20non-inferiority%20clinical%20study&rft.jtitle=International%20journal%20of%20rheumatic%20diseases&rft.au=Xin,%20Yang&rft.date=2016-03&rft.volume=19&rft.issue=3&rft.spage=271&rft.epage=278&rft.pages=271-278&rft.issn=1756-1841&rft.eissn=1756-185X&rft_id=info:doi/10.1111/1756-185X.12782&rft_dat=%3Cproquest_cross%3E1777076496%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1776114253&rft_id=info:pmid/26555862&rfr_iscdi=true |